英文别名 |
1-(4-Fluorophenyl)-4-(4-(pyridin-2-yl)piperazin-1-yl)butan-1-one;4-fluoro-4-(4-(2-pyridyl)piperazin-1-yl)butyrophenone;Azaperone VETRANAL;1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one;1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butznone;Azaperone;1-(4-Fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanone;1-(4-fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one;1-<3-(4-Fluorbenzoyl)propyl>-4-(2-pyridyl)piperazin;4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone;Azaperon;Azeperone;Eucalmyl;Fluoperidol;R-1929;Sedaperone vet;Stresnil;Suicalm;1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone;r1929;NSC 170976;Azaperona;Azaperonum;1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-;Azaperonum [INN-Latin];Azaperona [INN-Spanish];1-(3-(4-Fluorobenzoyl)propyl)-4-(2-pyridyl)piperazine;C19H22FN3O;4'-Fluoro-4-(4-(2-pyridyl)-1-piperazinyl)butyrophenone;R 1929;MLS003106;Azaperonum (INN-Latin);SW196387-3;HMS2093D03;SMR001233462;1-(4-Fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one(Azaperone);HY-B1470;Azaperone, European Pharmacopoeia (EP) Reference Standard;Butyrophenone, {4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-};KS-5204;AZAPERONE [USP MONOGRAPH];1-Butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-;BRN 0565491;HMS3369I10;Azaperone for veterinary use;XTKDAFGWCDAMPY-UHFFFAOYSA-N;BDBM50036733;KBio3_002914;Azaperone (1.0 mg/mL in Methanol);NSC-758969;D02620;Azaperone (USP/INN);CAS-1649-18-9;1649-18-9;s4219;SBI-0206748.P001;NCGC00016590-01;CCRIS 1586;Stresnil (TN);DTXCID0025361;FT-0602908;MLS002154163;HMS2230C17;CHEMBL340211;AB00514057;Prestwick3_001117;AZAPERONE (USP-RS);19BV78AK7W;SPBio_003117;HMS3715O16;Azaperone (USAN:USP:INN:BAN);1-(4-fluorophenyl)-4-[4-(2-pyridyl)piperazin-1-yl]butan-1-one;Azaperone [USAN:USP:INN:BAN];HMS2098O16;AB00514057_07;1-(4-Fluorophenyl-d4)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanone, 4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone-d4;1-(4-Fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-;1-Butanone, {1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-};A810604;HMS3652D15;SPBio_001160;Azaperone, United States Pharmacopeia (USP) Reference Standard;AZAPERONE [USP IMPURITY];C73189;BPBio1_001379;PDSP2_000815;L000791;MLS003106751;AZAPERONE [GREEN BOOK];MFCD00866692;Stresnil Injection;Q4832244;AKOS005622715;J-010171;NSC170976;CCG-39158;NSC758969;AZAPERONE [MI];NCGC00016590-03;SY067157;BRD-K45861246-001-05-0;UNII-19BV78AK7W;NCGC00016590-08;4'-Fluoro-4-[4-(2-pyridinyl)-1-piperazinyl]butyrophenone;NCGC00095171-01;AZAPERONE (USP MONOGRAPH);BSPBio_003566;Prestwick2_001117;Azaperone, VETRANAL(TM), analytical standard;SR-05000001712-1;BRD-K45861246-001-08-4;5-23-03-00041 (Beilstein Handbook Reference);NS00000088;1-(4-fluorophenyl)-4-[4-(pyridin-2-yl)piperazin-1-yl]butan-1-one;Spectrum2_001250;AZAPERONE [INN];AM84563;N... |